5α-Reductase Inhibitors Are Associated with Reduced Risk of SARS-CoV-2 Infection: A Matched-Pair, Registry-Based Analysis
Lyon et al., Journal of Urology, doi:10.1097/JU.0000000000002180
https://c19early.org/lyon.html